The Patent Finder

Genelux Corporation

11 patents currently held · Updated Nov 18, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
7
Ending by 2030
Nov 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 18, 2027.

Recent changes

  • 1 term has ended since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,588,767Microorganisms for Therapy
In force
 · High confidence
In forceHigh confidence
US 7,763,420Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,066,984Modified Vaccinia Virus Strains for Use in Diagnostic and Therapeutic Methods
In force
 · High confidence
In forceHigh confidence
US 9,944,903Modified Vaccinia Virus Strains for Use in Diagnostic and Therapeutic Methods
In force
 · High confidence
In forceHigh confidence
US 10,584,317Modified Vaccinia Virus Strains for Use in Diagnostic and Therapeutic Methods
In force
 · High confidence
In forceHigh confidence
US 9,005,602Modified Vaccinia Virus Strains for Use in Diagnostic and Therapeutic Methods
In force
 · High confidence
In forceHigh confidence
US 8,052,968Modified Vaccinia Virus Strains for Use in Diagnostic and Therapeutic Methods
In force
 · High confidence
In forceHigh confidence
US 11,149,254Clonal strains of attenuated vaccinia viruses and methods of use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,338,464Clonal strains of attenuated vaccinia viruses and methods of use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,238,700Oncolytic virus adjunct therapy with agents that increase virus infectivity
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
Also on record, not counted in the 11: 2 patents in force now held by others · 9 lapsed for an unpaid fee · 11 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

Every application published under this name has become a patent.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited